(3S,3aS,6aR)-4-(5-((Cyclopropylamino)methyl)pyrazine-2-carbonyl)-3-isopropyl-1-(methylsulfonyl)hexahydropyrrolo[3,2-b]pyrrol-2(1H)-one

Catalog No. :
ACNRPW521
CAS No. :
221323-41-7
Molecular Formula :
C19H27N5O4S
Molecular Weight :
421.52

IUPAC Name:(3S,3aS,6aR)-4-(5-((cyclopropylamino)methyl)pyrazine-2-carbonyl)-3-isopropyl-1-(methylsulfonyl)hexahydropyrrolo[3,2-b]pyrrol-2(1H)-one

(3S,3aS,6aR)-4-(5-((Cyclopropylamino)methyl)pyrazine-2-carbonyl)-3-isopropyl-1-(methylsulfonyl)hexahydropyrrolo[3,2-b]pyrrol-2(1H)-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(3S,3aS,6aR)-4-(5-((Cyclopropylamino)methyl)pyrazine-2-carbonyl)-3-isopropyl-1-(methylsulfonyl)hexahydropyrrolo[3,2-b]pyrrol-2(1H)-one
IUPAC Name(3S,3aS,6aR)-4-(5-((cyclopropylamino)methyl)pyrazine-2-carbonyl)-3-isopropyl-1-(methylsulfonyl)hexahydropyrrolo[3,2-b]pyrrol-2(1H)-one
Molecular FormulaC19H27N5O4S
Molecular Weight421.52
SMILES[C@@H](C)(C)[C@H]1[C@]2([C@](N(S(C)(=O)=O)C1=O)(CCN2C(=O)C=3C=NC(CNC4CC4)=CN3)[H])[H]
InChI KeyTZSPKNFWFIBCTO-IXDOHACOSA-N
SynonymPyrrolo[3,2-b]pyrrol-2(1H)-one, 4-[[5-[(cyclopropylamino)methyl]-2-pyrazinyl]carbonyl]hexahydro-3-(1-methylethyl)-1-(methylsulfonyl)-, (3S,3aS,6aR)-
CAS No.221323-41-7

Synthetic Route by SureRoute

1. ACNRPW521 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACNQUT007 route compound structure diagram
    ACNQUT00718600-39-0 In Stock
  4. Then
  5. ACNRPW521 route product structure diagram
    ACNRPW521221323-41-7
Inquiry

2. ACNRPW521 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACNRPW521 route product structure diagram
    ACNRPW521221323-41-7
Inquiry

Comments (0)